12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·21 hours agoGCTK-6.91%EYPT-66.98%
Apimeds net loss widens to $20.17 million in Q2 2026; R&D expenses rise 47% to $959,742 vs year-ago quarterPUBT·Aug 14 at 03:31 PMAPUS-5.93%
Apimeds Pharmaceuticals names Christopher Kim chief scientific officerPUBT·Aug 6 at 05:26 PMAPUS-5.93%
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga_article·Jul 29 at 12:06 PMAVTR-1.17%MBRX-0.85%
Apimeds Clears Merger Hurdle While Nucor Boosts Q2 Outlook: The Niche US Stocks Reshaping Their SectorsGlobal Report·Jul 26 at 04:18 AMAPUS-5.93%NUE+1.40%
Strategic Pivots and the Value Chain: The Unbundling of Core Business ModelsGlobal Report·Jul 26 at 04:14 AMGPUS0.00%NLST+2.55%
Megadeals and PIPE Lifelines: Inside the USD 4.3B Wheaton Stream and XCF's War ChestGlobal Report·Jul 25 at 04:18 AMAPUS-5.93%SGAPY+0.46%
The Quiet Restructuring of 2026: Survival Tactics from 10 Niche Market PlayersGlobal Report·Jul 25 at 04:13 AMCYCU+6.79%ADP-2.53%
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga_article·Jul 21 at 04:05 PMNDRA+0.45%VTAK-18.57%
Pre-market hot trades in US stocks: Cuprina pre-market down 8.35%; Apimeds Pharmaceuticals US pre-market down 7.78%Price Alert·Jul 1 at 03:56 AMCUPR-2.99%APUS-5.93%
Pre-market hot trades in US stocks: Apimeds Pharmaceuticals US up 23.54% in pre-market; IREN down 3.12% in pre-marketPrice Alert·Jun 26 at 06:47 AMAPUS-5.93%IREN+1.91%
Pre-market hot trades in US stocks: Fundrise Innovation Fund LLC pre-market down 8.33%; Apimeds Pharmaceuticals US pre-market down 7.99%Price Alert·Jun 23 at 07:52 AMVCX+19.19%APUS-5.93%
Apimeds Pharmaceuticals US | 10-Q: FY2026 Q1 Revenue: USD 0Earnings Watch·May 26 at 03:08 PMAPUS-5.93%
